$AVEO News Article - AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA ) in Combination with IMFINZI (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma https://marketwirenews.com/news-releases/aveo...29872.html